glyburide has been researched along with interleukin-8 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beleznay, Z; Bickel, M; Lottaz, D | 1 |
| Ambrosio, SR; Arakawa, NS; Casagrande, R; Cunha, FQ; Cunha, TM; Ferreira, SH; Mizokami, SS; Verri, WA; Zarpelon, AC | 1 |
| Ato, M; Bancroft, GJ; Kewcharoenwong, C; Lertmemongkolchai, G; Rinchai, D; Suwannasaen, D; Utispan, K | 1 |
| Bancroft, GJ; Fletcher, HA; Kewcharoenwong, C; Lertmemongkolchai, G; Saenwongsa, W; Willcocks, SJ | 1 |
4 other study(ies) available for glyburide and interleukin-8
| Article | Year |
|---|---|
Inhibition of ATP-binding cassette transporter downregulates interleukin-1beta-mediated autocrine activation of human dermal fibroblasts.
Topics: Animals; ATP-Binding Cassette Transporters; Autocrine Communication; Cells, Cultured; COS Cells; Down-Regulation; Fibroblasts; Glyburide; Humans; Interleukin-1; Interleukin-8; Skin; Skin Physiological Phenomena; Transfection; Tumor Necrosis Factor-alpha | 2001 |
Kaurenoic acid from Sphagneticola trilobata Inhibits Inflammatory Pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.
Topics: Acetic Acid; Administration, Oral; Animals; Asteraceae; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Cytokines; Diterpenes; Dose-Response Relationship, Drug; Formaldehyde; Freund's Adjuvant; Glyburide; Inflammation; Injections, Intraperitoneal; Interleukin-8; KATP Channels; Mice; Molecular Structure; NG-Nitroarginine Methyl Ester; Pain; Tumor Necrosis Factor-alpha | 2012 |
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.
Topics: Burkholderia pseudomallei; Diabetes Mellitus, Type 2; Disease Susceptibility; Glyburide; Humans; Hypoglycemic Agents; Interleukin-1beta; Interleukin-8; Melioidosis; Metformin; Neutrophils; Thailand | 2013 |
Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.
Topics: Adult; Aged; Case-Control Studies; Cells, Cultured; Diabetes Mellitus, Type 2; Dinoprostone; Female; Glyburide; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Interferon-alpha; Interleukin-1beta; Interleukin-8; Male; Middle Aged; Monocytes; Mycobacterium bovis; Mycobacterium tuberculosis; Risk Assessment; Tuberculosis | 2020 |